{"category": "ham", "to_address": "Sue Rochman <sue.rochman@earthlink.net>, <ip-health@lists.essential.org>", "from_address": "Joel Lexchin <joel.lexchin@utoronto.ca>", "subject": "Re: [Ip-health] drug naming/patents/exclusivity", "body": "There are a few other examples that I know of:\n\nLilly sells fluoxetine as Prozac (antidepressant) and Serafem (premenstrual\ndysphoric disorder)\n\nGSK sells buproprion as Wellbutrin (antidepressant) and Zyban (smoking\ncessation)\n\nJoel Lexchin\n\n--\nJoel Lexchin MD\n121 Walmer Rd.\nToronto ON\nCanada M5R 2X8\nTel: 416-964-7186\nFax: 416-736-5227\nE mail: joel.lexchin@utoronto.ca\n\n\n\n_______________________________________________\nIp-health mailing list\nIp-health@lists.essential.org\nhttp://lists.essential.org/mailman/listinfo/ip-health\n\n"}